Avalon Investment & Advisory’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $1.61M | Sell |
21,149
-815
| -4% | -$62.1K | 0.04% | 178 |
|
|
2022
Q4 | $1.82M | Sell |
21,964
-253
| -1% | -$21K | 0.05% | 172 |
|
|
2022
Q3 | $1.76M | Sell |
22,217
-1,393
| -6% | -$110K | 0.05% | 169 |
|
|
2022
Q2 | $1.75M | Sell |
23,610
-885
| -4% | -$65.7K | 0.05% | 172 |
|
|
2022
Q1 | $2.2M | Buy |
24,495
+2,765
| +13% | +$249K | 0.05% | 166 |
|
|
2021
Q4 | $2.43M | Sell |
21,730
-3,623
| -14% | -$406K | 0.06% | 161 |
|
|
2021
Q3 | $3.19M | Buy |
25,353
+664
| +3% | +$83.5K | 0.07% | 166 |
|
|
2021
Q2 | $3.34M | Buy |
24,689
+2,153
| +10% | +$292K | 0.07% | 168 |
|
|
2021
Q1 | $3.06M | Buy |
22,536
+893
| +4% | +$121K | 0.07% | 166 |
|
|
2020
Q4 | $3.05M | Sell |
21,643
-582
| -3% | -$81.9K | 0.06% | 173 |
|
|
2020
Q3 | $2.48M | Sell |
22,225
-3,004
| -12% | -$335K | 0.06% | 169 |
|
|
2020
Q2 | $2.82M | Sell |
25,229
-7,316
| -22% | -$819K | 0.07% | 166 |
|
|
2020
Q1 | $2.52M | Sell |
32,545
-1,731
| -5% | -$134K | 0.06% | 180 |
|
|
2019
Q4 | $3.26M | Sell |
34,276
-194
| -0.6% | -$18.5K | 0.07% | 184 |
|
|
2019
Q3 | $2.63M | Sell |
34,470
-440
| -1% | -$33.5K | 0.06% | 190 |
|
|
2019
Q2 | $3.06M | Buy |
34,910
+314
| +0.9% | +$27.5K | 0.07% | 182 |
|
|
2019
Q1 | $3.13M | Buy |
34,596
+248
| +0.7% | +$22.5K | 0.07% | 182 |
|
|
2018
Q4 | $2.46M | Buy |
34,348
+1,765
| +5% | +$127K | 0.06% | 193 |
|
|
2018
Q3 | $3.12M | Buy |
32,583
+2,272
| +7% | +$218K | 0.09% | 204 |
|
|
2018
Q2 | $2.89M | Sell |
30,311
-6,977
| -19% | -$664K | 0.09% | 195 |
|
|
2018
Q1 | $3.27M | Buy |
37,288
+3,527
| +10% | +$309K | 0.1% | 162 |
|
|
2017
Q4 | $2.87M | Buy |
33,761
+1,129
| +3% | +$95.8K | 0.09% | 170 |
|
|
2017
Q3 | $2.83M | Sell |
32,632
-247
| -0.8% | -$21.4K | 0.09% | 161 |
|
|
2017
Q2 | $2.54M | Buy |
32,879
+427
| +1% | +$33K | 0.08% | 168 |
|
|
2017
Q1 | $2.25M | Buy |
32,452
+3,158
| +11% | +$219K | 0.08% | 173 |
|
|
2016
Q4 | $1.73M | Buy |
29,294
+108
| +0.4% | +$6.39K | 0.06% | 178 |
|
|
2016
Q3 | $1.94M | Buy |
+29,186
| New | +$1.94M | 0.07% | 149 |
|